High frequency of hepatocellular carcinoma in Mongolia; Association with mono-, or co-infection with hepatitis C, B, and delta viruses

被引:47
作者
Oyunsuren, Tsendsuren
Kurbanov, Fuat
Tanaka, Yasuhito
Elkady, Abeer
Sanduijav, Ruvjir
Khajidsuren, Onkhoon
Dagvadorj, Byambin
Mizokami, Masashi
机构
[1] Nagoya City Univ, Dept Clin Mol Informat Med, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan
[2] Mongolian Acad Sci, Inst Biol, Mol Biol Lab, Ulaanbaatar, Mongolia
[3] Natl Canc Ctr, Ulaanbaatar, Mongolia
[4] Hlth Sci Univ, Ulaanbaatar, Mongolia
[5] Minist Hlth, Liver Clin, Ulaanbaatar, Mongolia
关键词
Mongolia; HCC; co-infection; HBV; HCV; HDV;
D O I
10.1002/jmv.20755
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To investigate the association between viral infection pattern and hepatocellular carcinoma (HCC), 292 chronic hepatitis patients, including 108 with developed HCC were screened using serological and molecular genetics methods. Viral etiology was established in 267 (91.4%), anti-HCV detected in 198 (67.8%), and HBsAg in 124 (42.5%) including 93 (74.4%) cases with HDV co-infection. HCV mono-infection predominated in both, "non-HCC" and "HCC" groups (54% and 39%, respectively) with higher frequency in the first group (P=0.011), whereas HBV in co-infection with HDV was more frequent in HCC group (14% vs 25%, P=0.017). Patients with HCV monoinfection were older than those with co-infection (P < 0.02), had higher frequency of HCV-viraemia (82% vs 7%, P < 0.0001), and yet had significantly lower prevalence of HCC (29.6% vs. 49.1%, P=0.003). Alpha-fetoprotein (AFP) and protein induced by vitamin K antagonist-II (PIVKA-II) were specifically elevated in 71% of HCC patients. In conclusion, although HCV monoinfection pattern predominates in Mongolia, co-infection with HBV and HDV had stronger association with HCC development at younger age. Liver tumor markers; AFP and PIVKA-II are useful tools for complex HCC-screening and clinical follow-up for chronic hepatitis patients in Mongolia.
引用
收藏
页码:1688 / 1695
页数:8
相关论文
共 39 条
  • [1] Quantitation of hepatitis B virus genomic DNA by real-time detection PCR
    Abe, A
    Inoue, K
    Tanaka, T
    Kato, J
    Kajiyama, N
    Kawaguchi, R
    Tanaka, S
    Yoshiba, M
    Kohara, M
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (09) : 2899 - 2903
  • [2] Primary liver cancer:: Worldwide incidence and trends
    Bosch, FX
    Ribes, J
    Díaz, M
    Cléries, R
    [J]. GASTROENTEROLOGY, 2004, 127 (05) : S5 - S16
  • [3] Viral replication in patients with concomitant hepatitis B and C virus infections
    Crespo, J
    Lozano, JL
    Carte, B
    delasHeras, B
    delaCruz, F
    PonsRomero, F
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (06) : 445 - 451
  • [4] Donato F, 1998, INT J CANCER, V75, P347, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt
  • [5] 347::AID-IJC4&gt
  • [6] 3.0.CO
  • [7] 2-2
  • [8] DULAMSUREN S, 2004, REPORT MINISTRY HLTH, V58
  • [9] Fujioka S, 1998, Kansenshogaku Zasshi, V72, P5
  • [10] Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma
    Fujiyama, S
    Tanaka, M
    Maeda, S
    Ashihara, H
    Hirata, R
    Tomita, K
    [J]. ONCOLOGY, 2002, 62 : 57 - 63